MedPath

high-flow nasal oxygen therapy after esophagectomy for thoracic esophageal cancer

Not Applicable
Conditions
after esophagectomy for thoracic esophageal cancer
Registration Number
JPRN-UMIN000023617
Lead Sponsor
Juntendo University School of Medicine
Brief Summary

The nasal high-flow therapy group prevented the deterioration of oxygenation compared with the Venturi mask therapy group at POD2. The total fluid balance continued plus balance until POD2 in both groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
63
Inclusion Criteria

Not provided

Exclusion Criteria

not intubated patient

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath